About Us

News and Press Releases

2012 News

• March 1, 2012
  Nationwide Educational Tour Kicks Off on the Future of Molecular Diagnostics
• February 13, 2012
  BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies to Offer Integrated Microbiology Lab Solutions
• February 13, 2012
  BD Acquires KIESTRA Lab Automation BV

2011 News

• December 19, 2011
  New BD Veritor™ System for Rapid Detection of Flu A+B Receives 510(k) Clearance and CLIA Waiver
• November 24, 2011
  New, Fully Automated BD MAX™ MRSA Assay Rapidly Identifies Patients Colonized with Deadly Superbug
• September 13, 2011
  BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative®
• August 18, 2011
  BD Diagnostics and Biodiversity Collaborate to Develop Portfolio of Assays on the BD MAX™ System
• August 3, 2011
  BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System
• July 1, 2011
  BD Diagnostics Hires Leading Infectious Disease Diagnostics Expert to Strengthen New Product Pipeline
• May 19, 2011
  BD Launches BD MAX™ System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases
• May 9, 2011
  BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System
• May 8, 2011
  Bruker Announces Integrated Microbiology Workflow For MALDI Biotyper Microbial Identification and BD Phoenix™ Antibiotic Susceptibility Testing
• March 28, 2011
  BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens
• March 21, 2011
  World TB Day Donation Campaign Increases Access to Improved TB Tests in Resource-Limited Settings
• February 16, 2011
  BD Expands Industrial Microbiology Rapid Methods Portfolio
• February 9, 2011
  BD and UCL Business Reach Exclusive License Agreement to Advance Development of New Diagnostic Tests for Ovarian and Breast Cancers
• January 3, 2011
  New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients

2010 News

• December 20, 2010
  BD Diagnostics Facility in Mebane, North Carolina Achieves LEED Silver Certification for Green Building Design
• November 16, 2010
  BD Taps Leading Voice in Infection Prevention Community to Advance Efforts to Reduce Healthcare-Associated Infections
• October 25, 2010
  BD Diagnostics and Lonza Collaborate to Commercialize the Lonza microCompass™ Molecular Assays on the BD MAX™ System
• September 29, 2010
  BD Diagnostics and Bruker Collaborate to Improve Microbial Identification and Antimicrobial Susceptibility Testing
• August 3, 2010
  BD Receives CLIA "Moderate Complexity" Status for the BD MAX™ GBS Assay
• June 17, 2010
  Launch of BD BACTEC™ MGIT™ 320 System Expands TB Detection Worldwide
• June 2, 2010
  BD Announces First FDA-Cleared Assay on the BD MAX™ System to Detect Group B Streptococcus
• May 20, 2010
  BD Celebrates Opening of Manufacturing Facility in Mebane, North Carolina
• April 6, 2010
  BD Expands Diagnostics Portfolio with Advanced Automated Microbiology Specimen Processor
• March 18, 2010
  BD Diagnostics Launches the BD Protect™ Infection Surveillance and Prevention Software Portfolio
• February 3, 2010
  BD Launches "Be a Flu Fighter" Campaign to Promote Influenza Awareness and Prevention in Schools, Hospitals and Laboratories

2009 News

• December 7, 2009
  BD Expands Diagnostic Testing Offerings in Women's Health
• November 20, 2009
  BD Completes Acquisition of HandyLab, Inc.
• November 5, 2009
  BD Diagnostics Launches Turnkey Continuing Education Program for Clinical Laboratories
• October 23, 2009
  BD Announces Agreement to Acquire HandyLab, Inc.
• August 6, 2009
  BD Adds Surveillance Capability to Infectious Disease Portfolio
• March 23, 2009
  BD Announces FDA 510(k) Clearance of BD ProbeTec™ Q^x Amplified Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
• February 10, 2009
  BD Announces CE Marking of BD ProbeTec™ Q^x Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
• January 14, 2009
  New BD BACTEC™ FX Blood Culture System with the BD EpiCenter™ Operating System now Available Worldwide
• January 12, 2009
  BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections

2008 News

• July 7, 2008
  BD GeneOhm™ Cdiff Assay Submitted for FDA Clearance
• June 2, 2008
  New BD BACTEC™ FX Blood Culture Instrument with the BD EpiCenter™ Operating System can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections
• April 8, 2008
  BD Opens New Manufacturing Facility in Suzhou, China to Produce Rapid Diagnostic Products
• March 27, 2008
  BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana
• March 17, 2008
  BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates
• January 2, 2008
  BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures

2007 News

• December 20, 2007
  BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens
• September 11, 2007
  BD Announces FDA 510(k) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
• May 22, 2007
  BD Demonstrates Microbiology Automation Designed to Improve Laboratory Efficiency of Microbial Identification and Susceptibility Testing
• April 26, 2007
  Ability of the BD ProbeTec™ ET System to Detect Variant Chlamydia trachomatis is Confirmed
• March 22, 2007
  BD and FIND Announce Expanded Collaboration to Improve Tuberculosis Diagnostics Worldwide
• March 9, 2007
  BD Honored as One of "America's Most Admired Companies" in FORTUNE Magazine's Annual Rankings
• February 8, 2007
  BD Commits $34 Million for Major Expansion in Québec

2006 News

• December 20, 2006
  BD Completes Acquisition of TriPath Imaging, Expands Presence in Cancer Diagnostics Market
• July 18, 2006
  BD Invests US$16 Million to Establish a Plant in China To Produce Rapid Diagnostic Products for Flu and Virus Infection
• June 15, 2006
  BD Diagnostics Announces Agreement with BioReference Laboratories for BD Viper™ Robotic Instrumentation and Molecular Testing of Sexually Transmitted Infections
• February 23, 2006
  BD Diagnostics Announces Multi-year Agreement with Quest Diagnostics for BD Viper™ System
• January 9, 2006
  BD Diagnostics Announces FDA 510(k) clearance of the BD Viper™ System

2005 News

• October 19, 2005
  BD Diagnostics Announces FDA 510(k) Clearance for BD ProbeTec™ Urine Preservative Transport (UPT)
• September 22, 2005
  BD Diagnostics Announces FDA 510(k) Clearance of BD Directigen™ EZ Flu A+B Test
• August 31, 2005
  BD Directigen™ EZ Flu A+B Test - A better option for Flu testing is now available
• August 10, 2005
  BBL™ CHROMagar™ Listeria Receives AOAC™ Certification for the Direct Identification of L. monocytogenes and L. ivanovii
• July 18, 2005
  BD Universal Viral Transport - Room Temperature Viability
• June 2, 2005
  Launching Our Newly Reconfigured Web Site
• April 10, 2005
  BBL™ CHROMagar™ Salmonella Medium Receives AOAC-RI Approval
• March 30, 2005
  BD EpiCenter™ Version 5: Provides New Capabilities
• January 11, 2005
  BD GasPak™ EZ Gas Generating Systems are rapid, waterless and catalyst-free
• January 10, 2005
  BD Announces FDA 510(k) clearance of simplified test for detection of methicillin-resistant Staphylococcus aureus (MRSA)
• January 1, 2005
  BBL™ CHROMagar™ Orientation - Save time and reduce costs with a single plate culture system that identifies 80% of urinary pathogens without confirmatory testing.